Market By Product, Test Type, Technology And Geography | Forecast 2019-2027
Triton's research report anticipates the Latin America newborn screening market to upsurge with a CAGR of 12.91% in the forecast period of 2019 to 2027.
The countries considered in the report on Latin America’s newborn screening market are:
• Brazil
• Mexico
• Rest of Latin America
Report scope can be customized per your requirements. Request For Customization
In Mexico, the most pivotal step is that the secretary of Health and the Mexican Social Security Institute together has screened more than 70% of all newborns in the country, which is further augmenting the growth of the newborn screening market in the Latin American region. According to the Canadian PKU and Allied Disorders Association, the combined population accounts for around 600 million, with annual births that account for 11 million. The newborn screening programs that have been going on for around 20-30 years in the countries which mainly include Cuba, Costa Rica, Uruguay and Chile are constantly focusing on expanding their coverage, and in the present scenario, all these four countries have a reach to around 99% of the newborn population of the country. According to the association, Chile has expanded newborn screening to include around 25 conditions in 2015, and the researchers in Cuba have reported on launching several new screening techniques considering both traditional and future screening. In the present scenario, newborn screening in Cuba has been decentralized through more than 175 laboratories.
A rise in the global population of the world has been observed, owing to the rising fertility rate. According to the WHO, 130 million infants are born in per year, of which 2.6 million die in the first 28 days of their life. Newborn infants are more prone to infection, which can occur at any time from the first day of life. Newborn screening tests are done to diagnose the congenital or inborn abnormalities of metabolism to identify the disease in neonatal investigations. The growing fertility rate is likely to raise the demand for newborn screening market. These tests are done immediately after the birth of the baby, and are able to detect metabolic, genetic and developmental disorders in newborns.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA NEWBORN SCREENING MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.2.1. DEMAND
FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
2.2.2. GROWTH
IN DRY BLOOD SPOT TEST
2.2.3. TECHNIQUES
USED IN NEWBORN SCREENING TESTS
2.3. EVOLUTION
& TRANSITION OF NEWBORN SCREENING
2.4. PORTER’S
FIVE FORCE ANALYSIS
2.4.1. THREAT
OF NEW ENTRANTS
2.4.2. THREAT
OF SUBSTITUTE
2.4.3. BARGAINING
POWER OF SUPPLIERS
2.4.4. BARGAINING
POWER OF BUYERS
2.4.5. THREAT
OF COMPETITIVE RIVALRY
2.5. KEY
IMPACT ANALYSIS
2.5.1. RELIABILITY
2.5.2. COST
2.5.3. AVAILABILITY
2.5.4. TECHNOLOGICAL
ADVANCEMENT
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. INDUSTRY
COMPONENTS
2.8.1. RAW
MATERIAL SUPPLIERS
2.8.2. MANUFACTURERS
2.8.3. DISTRIBUTORS
2.8.4. END-USERS
2.9. REGULATORY
FRAMEWORK
2.10. INDUSTRY
PLAYER POSITIONING
2.11. KEY
MARKET STRATEGIES
2.11.1. PRODUCT
LAUNCH
2.12. MARKET
DRIVERS
2.12.1. INCREASE
IN OCCURRENCES OF NEWBORN DISEASES
2.12.2. GROWING
NUMBER OF INFANTS WITH BIRTH DEFECT
2.12.3. BACKING
OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
2.12.4. RISING
AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
2.13. MARKET
RESTRAINTS
2.13.1. ABSENCE
OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
2.13.2. SOCIO-ECONOMIC
HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
2.14. MARKET
OPPORTUNITIES
2.14.1. INCREASING
FERTILITY RATES ACROSS THE GLOBE IS CREATING DYNAMIC GROWTH
2.14.2. NEWBORN
SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
2.14.3. TECHNOLOGICAL
ADVANCEMENTS IN NEWBORN SCREENING
2.14.4. INCREASE
IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
2.15. MARKET
CHALLENGES
2.15.1. DEARTH
OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
2.15.2. MAINTENANCE
OF EQUIPMENT IN HOSPITAL
3. NEWBORN
SCREENING MARKET OUTLOOK - BY PRODUCT
3.1. NEWBORN
SCREENING INSTRUMENTS
3.2. NEWBORN
SCREENING REAGENTS & ASSAY KITS
4. NEWBORN
SCREENING MARKET OUTLOOK - BY TEST TYPE
4.1. HEARING
SCREEN TEST
4.2. CRITICAL
CONGENITAL HEART DISEASE (CCHD) TEST
4.3. DRY
BLOOD SPOT TEST
5. NEWBORN
SCREENING MARKET OUTLOOK - BY TECHNOLOGY
5.1. TANDEM
MASS SPECTROMETRY
5.2. PULSE
OXIMETRY
5.3. ENZYME-BASED
ASSAYS
5.4. DNA-BASED
ASSAYS
5.5. ELECTROPHORESIS
5.6. OTHERS
6. NEWBORN
SCREENING MARKET - REGIONAL OUTLOOK
6.1. BRAZIL
6.2. MEXICO
6.3. REST
OF LATIN AMERICA
7. COMPETITIVE
LANDSCAPE
7.1. SCIEX
7.2. BIOTEK
INSTRUMENTS, INC.
7.3. BIO-RAD
LABORATORIES, INC.
7.4. CARDINAL
HEALTH, INC.
7.5. GE
HEALTHCARE LIMITED
7.6. AGILENT
TECHNOLOGIES, INC.
7.7. MASIMO
CORPORATION
7.8. NATUS
MEDICAL, INCORPORATED
7.9. MEDTRONIC
PLC
7.10. THERMO
FISHER SCIENTIFIC, INC.
7.11. NEOGEN
LABS PVT. LTD.
7.12. PERKINELMER,
INC.
7.13. ZENTECH
S.A.
7.14. WATERS
CORPORATION
7.15. TRIVITRON
HEALTHCARE
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA
NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2: MARKET
ATTRACTIVENESS INDEX
TABLE 3: VENDOR
SCORECARD
TABLE 4: REGULATORY
FRAMEWORK
TABLE 5: LIST OF
PRODUCT LAUNCHES
TABLE 6: INFANT
MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATHS/ 1000 LIVE BIRTHS)
TABLE 7: LATIN AMERICA
NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 8: LATIN AMERICA
NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 9: LATIN AMERICA
NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)
TABLE 10: LATIN AMERICA
NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE
FORCE ANALYSIS
FIGURE 2: KEY BUYING IMPACT
ANALYSIS
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: INDUSTRY
PLAYER POSITIONING IN 2018 (IN %)
FIGURE 5: FERTILITY
RATE (AVERAGE BIRTHS PER WOMAN IN %) IN 2017
FIGURE 6: LATIN AMERICA
NEWBORN SCREENING MARKET, BY NEWBORN SCREENING INSTRUMENTS, 2019-2027 (IN $
MILLION)
FIGURE 7: LATIN AMERICA
NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS & ASSAY KITS,
2019-2027 (IN $ MILLION)
FIGURE 8: LATIN AMERICA
NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)
FIGURE 9: LATIN AMERICA
NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST,
2019-2027 (IN $ MILLION)
FIGURE 10: LATIN
AMERICA NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $
MILLION)
FIGURE 11: LATIN
AMERICA NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $
MILLION)
FIGURE 12: LATIN
AMERICA NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)
FIGURE 13: LATIN
AMERICA NEWBORN SCREENING MARKET, BY ENZYME-BASED ASSAY, 2019-2027 (IN $
MILLION)
FIGURE 14: LATIN
AMERICA NEWBORN SCREENING MARKET, BY DNA-BASED ASSAYS, 2019-2027 (IN $ MILLION)
FIGURE 15: LATIN
AMERICA NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)
FIGURE 16: LATIN
AMERICA NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)
FIGURE 17: LATIN
AMERICA NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 18: BRAZIL
NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 19: MEXICO
NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 20: REST OF
LATIN AMERICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)